News
PepGen (PEPG) announced that based on the levels of dystrophin protein measured in the 10 mg/kg cohort of its CONNECT1-EDO51 study investigating PGN-EDO51 in Duchenne muscular dystrophy patients ...
PepGen Announces Positive Preclinical Data for PGN-EDO53, PGN-EDO45 and PGN-EDO44, Three Novel Duchenne Muscular Dystrophy Candidates PepGen, Inc Updated Mon, Nov 14, 2022, 8:00 AM 9 min read ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback